Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy.
Han D, Han Y, Guo W, Wei W, Yang S, Xiang J, Che J, Zhu L, Hang J, van den Ende T, van Laarhoven HWM, Li B, Ye Y, Li H. Han D, et al. Among authors: guo w. J Immunother Cancer. 2023 Nov 28;11(11):e007847. doi: 10.1136/jitc-2023-007847. J Immunother Cancer. 2023. PMID: 38016720 Free PMC article.
A multicenter randomized phase II trial of hyperthermia combined with TPF induction chemotherapy compared with TPF induction chemotherapy in locally advanced resectable oral squamous cell carcinoma.
Ren G, Ju H, Wu Y, Song H, Ma X, Ge M, Qiu W, Chen Y, He Y, Zhuang Q, Meng J, Guo W. Ren G, et al. Among authors: guo w. Int J Hyperthermia. 2021;38(1):939-947. doi: 10.1080/02656736.2021.1937714. Int J Hyperthermia. 2021. PMID: 34134574 Free article. Clinical Trial.
First results of migoprotafib, a potent and highly selective Src homology-2 domain-containing phosphatase 2 (SHP2) inhibitor in patients with advanced solid tumors.
Johnson ML, Wolf BB, Wang JS, Philipovskiy A, Shapiro GI, Bockorny B, Guo W, Shen J, Jen KY, LeRose M, Hunter TL, Padval M, Schmidt-Kittler O, Bhatia N, Dubey S, Suchomel J, Bendell JC, Jauhari S, Eng-Wong J, Lin JJ. Johnson ML, et al. Among authors: guo w. Mol Cancer Ther. 2024 Dec 5. doi: 10.1158/1535-7163.MCT-24-0466. Online ahead of print. Mol Cancer Ther. 2024. PMID: 39632729
16,526 results
You have reached the last available page of results. Please see the User Guide for more information.